{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.8","upperLimit":"61.0","value":"48.1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"52"}],"units":"Participants"}],"description":"Cumulative incidence of successful reconstitution to donor level is calculated.","dispersionType":"95% Confidence Interval","groups":[{"description":"All Patients","id":"OG000","title":"Treatment (Chemotherapy and Allogeneic SCT)"}],"paramType":"NUMBER","populationDescription":"Patients without completion of planned therapy (n=68) or without NK cell status (n=38) are excluded from analyses of TExp","reportingStatus":"POSTED","timeFrame":"At 5 years from HSCT date","title":"Cumulative Incidence of NK Cell Reconstitution","type":"PRIMARY","unitOfMeasure":"Percentage of participants"}